Regulation
Lady Gaga's Outer Bio Develops AI Biotech to Sustain Human Skin for Research
Outer Bio, the AI biotech startup co-founded by Michael Polansky, Lady Gaga's fiancé, has emerged from stealth mode with a groundbreaking platform that can keep donated human skin alive for four weeks. This innovation allows researchers to study the tissue's biological responses over an extended period, significantly enhancing drug testing methodologies.
The platform, named Yuna, extends the viability of human skin, which typically deteriorates within a week after removal. By preserving the tissue longer, researchers can observe critical biological processes such as collagen breakdown, inflammation, and cellular aging. The skin samples are sourced primarily from cosmetic procedures, ensuring a diverse donor pool across various demographics.
Outer Bio's approach aligns with regulatory shifts aimed at reducing animal testing in drug development. The FDA has been actively promoting alternatives, and Europe has already implemented strict bans on animal-tested cosmetics. With over 10,000 treatments logged from 300 donors, Yuna has demonstrated its ability to replicate conditions related to inflammation, aging, and sun damage.
Polansky, who previously managed Sean Parker's family office, emphasizes that biological data is the new frontier for AI advancements. Investors, including Wing Venture Capital and Initialized Capital, have committed approximately $23 million to support Outer Bio's mission. The startup's innovative model could redefine how biopharma teams and consumer brands approach drug development and toxicity testing.
FAQ
What is Outer Bio and what does it do?
Outer Bio is an AI biotech startup co-founded by Michael Polansky, which has developed a platform named Yuna that can keep donated human skin alive for four weeks, allowing researchers to study biological responses over an extended period.
How does Yuna extend the viability of human skin?
Yuna preserves human skin samples, which typically deteriorate within a week after removal, enabling researchers to observe critical biological processes such as collagen breakdown, inflammation, and cellular aging.
What are the sources of the skin samples used by Outer Bio?
The skin samples are primarily sourced from cosmetic procedures, ensuring a diverse donor pool across various demographics.
How does Outer Bio's work align with regulatory changes in drug testing?
Outer Bio's approach supports regulatory shifts aimed at reducing animal testing in drug development, as the FDA promotes alternatives and Europe has implemented strict bans on animal-tested cosmetics.
What kind of support has Outer Bio received for its mission?
Outer Bio has secured approximately $23 million in funding from investors, including Wing Venture Capital and Initialized Capital, to support its innovative platform and mission.